The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Purdue Pharma and the Sackler family have agreed to pay over $7 billion for their role in the opioid crisis. Posted: January ...

The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription ...

Members of the family who own OxyContin maker Purdue Pharma ... The deal, agreed to by Purdue Pharma, the Sackler family ...

Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

“The Sackler family relentlessly pursued profit at the ... Purdue Pharma introduced 10mg prescriptions of OxyContin in 1996 and marketed it as a nonaddictive drug to treat daily pain.